Probiodrug AG announced that Olivier Litzka, partner at Edmond de Rothschild Investment Partners (EdRIP) and member of the supervisory board of company since October 2009, will step down from his board position as of September 12, 2016. Mark Booth will leave company for personal reasons and will step down from his position as chief business officer as of August 15, 2016. His responsibilities will be taken over by Konrad Glund, CEO of company.